BioNexus Gene Lab Corp (BGLC)
Nasdaq: BGLC · Services-Medical Laboratories · Kuala Lumpur, MY · filing with the SEC since 2019
Filings
136 filings since 2017 beside 21 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Dec 3, 2025.
Filings a yearinsider forms included
12107637332923
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Jun 23, 2025.Listing warning from its exchange (8-K item 3.01): 5 times in the last 36 months, the newest Apr 30, 2025.SEC letters: 3 in the last 36 months, the newest Jun 6, 2024.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.A late-filing notice, Form NT 10-Q, filed Aug 14, 2025.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-Q, filed Nov 14, 2024.A late-filing notice, Form NT 10-K, filed Mar 28, 2024.A late-filing notice, Form NT 10-Q, filed Nov 14, 2023.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 7, 2026
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Oct 5, 2026
Mar 17, 2026
8-K items 7.01, 8.01, 9.01
Investor disclosure (Regulation FD); Other event · Current report
Mar 11, 2026
Dec 2, 2025
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Nov 28, 2025
Nov 13, 2025
8-K items 1.01, 7.01, 9.01
Major agreement signed; Investor disclosure (Regulation FD) · Current report
Nov 7, 2025
Nov 12, 2025
8-K items 1.01, 3.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report
Apr 30, 2025
8-K items 3.01, 7.01, 9.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Apr 3, 2025
8-K items 3.03, 5.03, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Apr 1, 2025
Feb 14, 2025
8-K items 3.02, 3.03, 5.03, 9.01
Shares sold without registration; Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Feb 11, 2025
40 of 136 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.